Form 8-K - Current report:
SEC Accession No. 0001178879-20-000017
Filing Date
2020-03-23
Accepted
2020-03-23 07:01:07
Documents
16
Period of Report
2020-03-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fold-20200323.htm   iXBRL 8-K 38981
2 EX-99.1 ex991org.htm EX-99.1 34850
8 image01.jpg GRAPHIC 127191
  Complete submission text file 0001178879-20-000017.txt   391702

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20200323.xsd EX-101.SCH 2607
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20200323_cal.xml EX-101.CAL 742
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20200323_def.xml EX-101.DEF 1706
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20200323_lab.xml EX-101.LAB 24261
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20200323_pre.xml EX-101.PRE 12678
12 EXTRACTED XBRL INSTANCE DOCUMENT fold-20200323_htm.xml XML 10926
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 20733536
SIC: 2834 Pharmaceutical Preparations